If approved, CagriSema would provide patients and healthcare professionals with an additional treatment option supported by results from the REDEFINE clinical program, including robust efficacy, high treatment completion rates, and a tolerability profile consistent with its underlying pharmacology
AesthetiChem 80 Norton Road Stockton-on-Tees TS18 2DE Trading as: AesthetiChem Company Registration no: 15324632 Premises GPhC no: 9012834 Superintendent Pharmacist: Pritesh Patel GPhC no: 2046857
These shots offer quick recovery after long busy days
We recommend that patients maintain the current dose, or lower the dose until symptoms resolve
We use only licensed, high-purity peptides and combine them with functional testing, lifestyle coaching, and physician oversight
If you stick to low or moderate intake, you are less likely to experience these issues